NSUN3 inhibitors, as a chemical classification, primarily focus on the disruption of the enzyme's RNA methyltransferase activity, which is central to mitochondrial tRNA methylation. Given the specificity and importance of RNA methylation, particularly in mitochondrial function, targeting NSUN3 requires a nuanced approach to ensure that the desired inhibitory effect is achieved without inadvertently affecting other cellular processes. Most inhibitors in this category either directly or indirectly interfere with the RNA methylation process.
A significant fraction of the chemicals in this class, such as 5-Azacytidine, Decitabine, and RG108, are analogs of cytosine or adenosine that get incorporated into RNA or DNA. Their incorporation can alter the native structure or prevent methyl groups from being added, hence indirectly affecting NSUN3's function. Others, like Sinefungin, directly target the methyltransferase action by competing for the binding sites, effectively reducing the enzyme's ability to methylate its targets. Another strategy is the inhibition of associated pathways. For instance, 3-Deazaneplanocin A and its analog DZNEP disrupt methylation processes by affecting the S-adenosylhomocysteine hydrolase, a key component in methyl group transfers.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
When incorporated into RNA, 5-AzaC mimics cytidine, potentially disrupting NSUN3's ability to recognize and methylate its target cytosines. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
Primarily a DNA methyltransferase inhibitor, its structural interference might affect RNA methyltransferases like NSUN3 by binding to the enzyme's active site. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Being an analog, it can be incorporated into RNA, thereby affecting NSUN3's recognition and methylation of genuine target residues. | ||||||
Adenosine, periodate oxidized | 34240-05-6 | sc-214510 sc-214510A | 25 mg 100 mg | $119.00 $364.00 | ||
This compound modifies adenosine residues, possibly altering RNA structures that NSUN3 targets, leading to reduced binding and methylation. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Acts as an inhibitor by mimicking the methyl donor S-adenosylmethionine (SAM), potentially competing with SAM for binding to NSUN3 and halting the methylation process. | ||||||
Meclofenamic Acid | 644-62-2 | sc-211780 | 5 mg | $402.00 | ||
Although it primarily targets other RNA methyltransferases, its interaction may obstruct NSUN3's active sites or RNA-binding domains. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Affects various cellular processes, including ion homeostasis, which can indirectly impact NSUN3's localization or stability in mitochondria. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
As an analog of 3-Deazaneplanocin A, DZNEP reduces available methyl groups, affecting the methylation capability of NSUN3. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
While its primary action is against viral RNA, its incorporation into host RNA might also affect structures or sequences targeted by NSUN3. | ||||||
1-Aminocyclopentanecarboxylic acid | 52-52-8 | sc-202392 | 1 g | $23.00 | ||
By inhibiting SAM synthesis, it reduces the availability of the primary methyl group donor, thus affecting NSUN3's methylation activity. | ||||||